APPLICATION
ANDA077936
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-19
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
MELOXICAMDiscontinued
MELOXICAM 7.5MG · TABLET · ORAL
MELOXICAMDiscontinued
MELOXICAM 15MG · TABLET · ORAL
Approval history
2024-11-21Labeling · Supplement 19 · standardAP
2024-11-19Labeling · Supplement 18 · standardAP
2016-10-17Labeling · Supplement 17 · standardAP
2016-10-17Labeling · Supplement 15 · standardAP
2016-10-17Labeling · Supplement 16 · standardAP
2013-06-13Labeling · Supplement 14 · standardAP
2010-12-02Labeling · Supplement 11AP
2010-07-07Labeling · Supplement 10AP
2008-10-09Labeling · Supplement 7AP
2008-06-28Labeling · Supplement 6AP
2008-02-11Labeling · Supplement 4AP
2007-06-19Labeling · Supplement 3AP
2007-06-07Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.